RXRX logo

RXRX

Profile

Full Name

Recursion Pharmaceuticals, Inc.

Ticker Symbol

RXRX

Exchange

NASDAQ

Country

United States

IPO

April 16, 2021

Indexes

Not included

Employees

800

Key Details

Price

$4.92

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$58.49M(+33.30% YoY)

Annual EPS

-$1.69(-6.96% YoY)

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Feb 28, 25 Leerink Partners
Market Perform
Feb 6, 25 Needham
Buy
Jan 8, 25 Keybanc
Overweight
Dec 11, 24 Needham
Buy
Nov 20, 24 Needham
Buy
Nov 7, 24 Needham
Buy
Sep 4, 24 Needham
Buy
Sep 3, 24 Leerink Partners
Market Perform
Sep 3, 24 Jefferies
Hold
Aug 9, 24 Needham
Buy

Institutional Ownership

  • What is the ticker symbol for Recursion Pharmaceuticals?
  • Does Recursion Pharmaceuticals pay dividends?
  • What sector is Recursion Pharmaceuticals in?
  • What industry is Recursion Pharmaceuticals in?
  • What country is Recursion Pharmaceuticals based in?
  • When did Recursion Pharmaceuticals go public?
  • Is Recursion Pharmaceuticals in the S&P 500?
  • Is Recursion Pharmaceuticals in the NASDAQ 100?
  • Is Recursion Pharmaceuticals in the Dow Jones?
  • When was Recursion Pharmaceuticals's last earnings report?
  • When does Recursion Pharmaceuticals report earnings?
  • Should I buy Recursion Pharmaceuticals stock now?

What is the ticker symbol for Recursion Pharmaceuticals?

The ticker symbol for Recursion Pharmaceuticals is NASDAQ:RXRX

Does Recursion Pharmaceuticals pay dividends?

No, Recursion Pharmaceuticals does not pay dividends

What sector is Recursion Pharmaceuticals in?

Recursion Pharmaceuticals is in the Healthcare sector

What industry is Recursion Pharmaceuticals in?

Recursion Pharmaceuticals is in the Biotechnology industry

What country is Recursion Pharmaceuticals based in?

Recursion Pharmaceuticals is headquartered in United States

When did Recursion Pharmaceuticals go public?

Recursion Pharmaceuticals's initial public offering (IPO) was on April 16, 2021

Is Recursion Pharmaceuticals in the S&P 500?

No, Recursion Pharmaceuticals is not included in the S&P 500 index

Is Recursion Pharmaceuticals in the NASDAQ 100?

No, Recursion Pharmaceuticals is not included in the NASDAQ 100 index

Is Recursion Pharmaceuticals in the Dow Jones?

No, Recursion Pharmaceuticals is not included in the Dow Jones index

When was Recursion Pharmaceuticals's last earnings report?

Recursion Pharmaceuticals's most recent earnings report was on Feb 28, 2025

When does Recursion Pharmaceuticals report earnings?

The next expected earnings date for Recursion Pharmaceuticals is May 9, 2025

Should I buy Recursion Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page